Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Diabetes Care|November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruptionA J Scheen, P Henrivaux, B Jandrain, et al.Annals of the New York Academy of Sciences|January 1, 1984
Acquired immune deficiency syndrome in Belgium and its relation to Central AfricaN Clumeck, J Sonnet, H Taelman, et al.Diabete & Metabolisme|March 1, 1983
Long-term management of insulin-treated diabetic patients with continuous subcutaneous insulin infusionJ C Daubresse, P Henrivaux, A Bailly, et al.Diabetes Care|September 1, 1987
Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSIIA J Scheen, P Henrivaux, B Jandrain, et al.Diabetologia|November 1, 1989
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patientsA J Scheen, J Gillet, J Rosenthaler, et al.Diabetes Care|July 1, 1984
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusionA Scheen, M Castillo, B Jandrain, et al.Acta Diabetologica Latina|January 1, 1985
B-cell response to a standardized breakfast in end-stage renal failureJ C Daubresse, P Henrivaux, F Dehout, et al.European Journal of Clinical Microbiology|June 1, 1985
Analysis of the interferon system in African patients with acquired immunodeficiency syndromeK Huygen, F Mascart-Lemone, S Cran, et al.HIV Medicine|February 19, 2010
HIV-1 proviral resistance mutations: usefulness in clinical practiceB Kabamba-Mukadi, A Duquenne, P Henrivaux, et al.European Journal of Pediatrics|December 1, 1986
LAV/HTLV-III infection in children of African origin: experience in BelgiumT Jonckheer, J Levy, P Van de Perre, et al.Pageof 1